Philips continues to demonstrate strong commitment to its ESG ambitions
21 Février 2023 - 09:00AM
Philips continues to demonstrate strong commitment to its ESG
ambitions
February 21, 2023
- 1.81 billion lives improved by Philips’ health technology
products, services and solutions
- Philips became the first health technology company to obtain
approval by the Science Based Targets initiative (SBTi) for its
entire value-chain CO2 emissions reduction targets, including Scope
1-3
- Continued recognition for sustainability leadership - received
CDP’s ‘A List’ rating for 10th year in a row
- Actively engaging with suppliers and customers to help reduce
emissions across the end-to-end healthcare value chain
- With 77% renewable energy usage, Philips is well ahead of its
2025 goal
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, has
made strong progress towards realizing its key Environmental,
Social, and Governance (ESG) ambitions. In 2022, Philips reached
1.81 billion people with its products and services, while further
reducing operational emissions, and indirect (scope 3) emissions
across the end-to-end healthcare value chain, together with its
suppliers.
“We continue to move closer to our aim of improving 2 billion
lives per year by 2025, while stepping up our sustainability
efforts in our operations and value chain,” said Marnix van
Ginneken, Chief ESG & Legal Officer at Royal Philips. “The
growing momentum across the healthcare industry and among customers
to reduce our collective environmental footprint encourages us on a
daily basis as we continue to strive to reduce emissions across the
end-to-end healthcare value chain and drive the shift to a circular
economy.”
Increasing social impactIllustrating the
company’s increasing social impact, Philips’ health technology
products, services and solutions improved 1.81 billion lives (1.67
billion in 2021), of which 202 million in underserved communities.
This takes Philips closer to its goal of improving 2 billion lives
per year by 2025, with 300 million in underserved communities. In
2022, improved access to care in underserved communities was driven
by shared-value partnerships, the development of innovative digital
solutions, and the roll-out of new business and financing models
that are both sustainable and scalable.
Other key developments within the social dimension include a 30%
representation of women in senior leadership roles, increased focus
on employee health and well-being (both physical and mental
health), and continued emphasis on ensuring a safe and healthy
workplace.
Creating sustainable innovationsIn 2022, the
contribution from circular revenues increased to 18% of sales
(2021: 16%). In 2022, Philips saw 10% more returns of large medical
equipment compared to 2021 and closed the loop on more than 3,500
systems. Additionally, consumers started to make use of the newly
introduced options to rent a Philips Avent breast pump or IPL Lumea
hair removal device.
EcoDesigned products and solutions increased
their revenue contribution to 71.7% (2021: 70.5%), supported by
grooming and beauty products that contain over 25% recycled
plastics and Oral Healthcare introducing its first brush heads
containing 75% bio-based materials. Demand for sustainable
healthcare systems is supported by the MR 5300 with its
industry-leading BlueSeal magnet, helping radiology departments
massively reduce the need for scarce helium gas.
Reducing operational emissions and wasteIn
addition to remaining carbon-neutral in its operations (since
2020), Philips achieved 77% (2021: 74%) renewable energy usage,
exceeding the 75% goal for 2025. It also reduced transport- and
distribution-related CO2 emissions by 22% through a stricter
air-freight policy and optimized warehouse locations.
Philips improved the circularity of its waste stream to 91%
(2021: 87%), increasingly recycling, re-using or reducing waste. An
example is the replacement of single use plastic in supplier
packaging with boxes that can be used repeatedly. As a result, less
than 0.1% of the remaining operational waste was land-filled, in
line with our zero-waste to landfill ambition.
Philips is also proud that CDP, a global NGO
that assesses the CO₂ emissions performance and management of
reporting companies, ranked Philips on the CDP Climate Change ’A’
List for the 10th time in a row, thanks to the company’s continued
climate performance and transparency.
Advancing towards low-carbon operations and value
chain In 2022, Philips became the first health technology
company with approval from the Science Based Targets initiative
(SBTi) for its entire value-chain CO₂ emissions reduction targets,
including Scope 1-3. In addition, 41% of suppliers (based on spend)
have now committed to science-based targets (2021: 28%) – Philips’
goal is 50% by 2025.
Progressing in governancePhilips’ commitment to
responsible and transparent governance is illustrated by the
publication of the Philips Human Rights Report 2022, in which
Philips updated stakeholders on its progress in addressing key
human rights over the past year, along with plans for continuous
improvement.
Philips continues to take an active role – in collaboration with
global institutions such as the International Financial Reporting
Standards (IFRS) Foundation, the World Economic Forum (WEF) and the
European Union – to help drive the evolution towards a standard
global ESG reporting framework.
For a full overview of Philips’ Environmental, Social, and
Governance achievements, read chapter 5 of the Philips Annual
Report 2022, which was published earlier today.
For further information, please contact:
Ben ZwirsPhilips Global Press OfficeTel.: +31 6 1521 3446E-mail:
ben.zwirs@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being through meaningful innovation. Philips’ patient- and
people-centric innovation leverages advanced technology and deep
clinical and consumer insights to deliver personal health solutions
for consumers and professional health solutions for healthcare
providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in
diagnostic imaging, ultrasound, image-guided therapy, monitoring
and enterprise informatics, as well as in personal health. Philips
generated 2022 sales of EUR 17.8 billion and employs approximately
77,000 employees with sales and services in more than 100
countries. News about Philips can be found at
www.philips.com/newscenter.
- Philips MR5300 in use
- Refurbishment process
Koninklijke Philips NV (EU:PHIA)
Graphique Historique de l'Action
De Nov 2023 à Déc 2023
Koninklijke Philips NV (EU:PHIA)
Graphique Historique de l'Action
De Déc 2022 à Déc 2023